Almac Group Ltd - Company Profile
Powered by 
All the data and insights you need on Almac Group Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Almac Group Ltd Strategy Report
- Understand Almac Group Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio encompasses diagnostics and biomarker development, clinical technologies, Active Pharmaceutical Ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Headquarters
United Kingdom
Address
Almac House, 20 Seagoe Industrial Estate, Craigavon, Northern Ireland, BT635QD
Website
www.almacgroup.com
Telephone
44 28 38332200
No of Employees
6,600
Industry
Pharmaceuticals and Healthcare
Revenue (2021)
$1.0B
Almac Group Ltd premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Biomarker Discovery and Development: | Cancer DSA |
| Companion Diagnostic Development | Xcel |
| Biomarker Clinical Trial Management | Rapidd |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In October, the company announced its plans to construct new manufacturing, production and diagnostic laboratory facilities at its global headquarters in Craigavon. |
| 2023 | Contracts/Agreements | In July, the company entered into an agreement with SBTi to reach net zero emissions by 2045. |
| 2022 | Contracts/Agreements | In November, the company and Agios Pharmaceuticals, Inc. partnered for the launch of its product PYRUKYND (mitapivat) in the United States. |
Competitor Comparison
| Key Parameters | Almac Group Ltd | IQVIA Holdings Inc | Alexion Pharmaceuticals Inc | Incyte Corp | Codexis Inc |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United States of America | United States of America | United States of America | United States of America |
| City | Craigavon | Durham | Boston | Wilmington | Redwood City |
| State/Province | Northern Ireland | North Carolina | Massachusetts | Delaware | California |
| No. of Employees | 6,600 | 87,000 | 3,000 | 2,524 | 174 |
| Entity Type | Private | Public | Private | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Alan Armstrong | Chief Executive Officer; Chairman | Executive Board | 2002 | - |
| Graeme McBurney | Chief Operating Officer | Senior Management | 2022 | - |
| John McQuaid | Managing Director - Almac Pharma Services; President - Almac Pharma Services | Senior Management | 2022 | - |
| Valarie Higgins | President - Almac Clinical Technologies; Managing Director - Almac Clinical Technologies | Senior Management | - | - |
| Paul Harkin, M.D. | President - Almac Diagnostics; Managing Director - Almac Diagnostics | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer